Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

TALS Talaris Therapeutics

Watchlist
1.720
+0.090+5.52%
Close  02/06 16:00 ET
1.7200.0000.00%
Post Mkt Price 02/06 16:01 ET
High
1.730
Open
1.650
Turnover
256.48K
Low
1.650
Pre Close
1.630
Volume
152.39K
Market Cap
71.76M
P/E(TTM)
Loss
52wk High
10.560
Shares
41.72M
P/E(Static)
Loss
52wk Low
0.890
Float Cap
22.28M
Bid/Ask %
-33.33%
Historical High
19.820
Shs Float
12.96M
Volume Ratio
0.20
Historical Low
0.890
Dividend TTM
--
Div Yield TTM
--
P/B
0.37
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.18%
Amplitude
4.91%
Avg Price
1.683
Lot Size
1
Float Cap
22.28M
Bid/Ask %
-33.33%
Historical High
19.820
Shs Float
12.96M
Volume Ratio
0.20
Historical Low
0.890
Dividend TTM
--
P/B
0.37
Dividend LFY
--
Turnover Ratio
1.18%
Amplitude
4.91%
Avg Price
1.683
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Talaris Therapeutics, Inc. engages in cell therapy. It develops methods of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Its technologies are used to treat inherited metabolic enzyme disorders, red blood cell disorders to induce tolerance to organ transplants, and to treat autoimmune disorders such as type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and scleroderma. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Louisville, KY.
CEO: Mr. Scott Requadt
Market: NASDAQ
Listing Date: 05/07/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist